Premium
Fracture with the newer bioresorbable vascular scaffolds
Author(s) -
Elwany Mostafa,
Di Palma Gaetano,
Cortese Bernardo
Publication year - 2017
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26995
Subject(s) - medicine , bioresorbable scaffold , optical coherence tomography , heel , scaffold , etiology , surgery , radiology , biomedical engineering , percutaneous coronary intervention , anatomy , pathology , myocardial infarction , cardiology
Bioresorbable vascular scaffolds (BVS) are being increasingly used in complex, real‐world lesions. The possibility of strut fractures is a rare entity with the use of drug eluting stents (DES), but has not yet been adequately described for the BVS technology. In this report, we present a case of scaffold fracture of DEsolve BVS (Elixir Medical Corporation, USA) that was diagnosed both angiographically and by optical coherence tomography(OCT). Scaffold fracture with the newer BVS is a new Achilles' heel in the BVS technology. This gap in knowledge about the etiology such as over‐expansion and potential predictors of strut fracture need to be deeply investigated before a widespread use of such technologies is adopted. © 2017 Wiley Periodicals, Inc.